sagasudi.com valid
SAGASU-DI 全文検索
医薬品情報
- Authority
- 46 reach 0 · trust 10 · quality 21 · freshness 15
- Tier
- listed
- llms.txt
- https://sagasudi.com/llms.txt
- Sections
- 5
- Links
- 1271
- Size
- 134742 bytes
- Registered
- 2016-10-29
- Country
- Japan Hosting inference
- Hosting country
- Japan Hosting inference
- Country evidence
- No published address evidence collected yet
- For agents
- Documentation: developer or product docs worth reading, nothing to call
- First seen
- 2026-10-24T05:29:18.280Z
- Last checked
- 2026-10-24T05:29:21.099Z
- Badge
Their llms.txt
The beginning of the file, from our validated copy saved 2026-10-24T05:29:18.288Z. Cached copy · Source on sagasudi.com
Generated by All in One SEO v4.8.8, this is an llms.txt file, used by LLMs to index the site.
# SAGASU-DI 全文検索
医薬品情報
## Sitemaps
- [XML Sitemap](https://sagasudi.com/sitemap.xml): Contains all public & indexable URLs for this website.
## 投稿
- [利用規約](https://sagasudi.com/利用規約/)
- [2024年12月に薬価収載される予定の新規成分の後発品](https://sagasudi.com/3539439854-2/)
- [医薬品供給状況を検索できるwebsite紹介](https://sagasudi.com/35893583-2/)
- [選定療養の計算ができるwebsite紹介](https://sagasudi.com/348574-2/)
- [【Q】トルカプ錠の新薬処方日数の投与制限は？](https://sagasudi.com/【q】トルカプ錠の新薬処方日数の投与制限は？/)
- [【Q】シスタドロップス点眼液0.38%の新薬処方日数の投与制限は？](https://sagasudi.com/5378729-2/)
- [【Q】ボイデヤ錠50mgの新薬処方日数の投与制限は？](https://sagasudi.com/274738-2/)
- [【Q】ターゼナカプセルの新薬処方日数の投与制限は？](https://sagasudi.com/4379327-2/)
- [医療用抗原検査キットは薬局でいつまで販売可能か？](https://sagasudi.com/47387-2/)
- [スチックゼノールAとフェルビナクスチック軟膏の違いは？](https://sagasudi.com/5839820-2/)
- [アポハイドローションの処方単位は？](https://sagasudi.com/438984-2/)
- [ユニフィルLA錠の販売中止](https://sagasudi.com/85397439-2/)
- [フェルビナクローション3%, 外用ポンプスプレー3%「三笠」販売中止](https://sagasudi.com/3583937-2/)
- [2024年7月1日からのラゲブリオの薬価](https://sagasudi.com/49583902-2/)
- [2024年4月17日に薬価収載される薬](https://sagasudi.com/438738-2/)
- [【Q】アリドネパッチの新薬処方日数の投与制限は？](https://sagasudi.com/32439032-2/)
- [2024年6月に薬価収載の後発品 (新規成分)](https://sagasudi.com/202402224302-2/)
- [2023年12月に薬価収載の後発品 (新規成分)](https://sagasudi.com/53895839-2/)
- [尿素クリーム「フジナガ」 10%,20% 経過措置期間は？](https://sagasudi.com/202402053893-2/)
- [ジヒドロコデインリン酸塩散1%「第一三共」 経過措置期間は？](https://sagasudi.com/20240205339-2/)
- [コデインリン酸塩散1%「第一三共」 経過措置期間は？](https://sagasudi.com/20240205221-2/)
- [2024年 調剤報酬改定 地域体制加算１と２ (10項目)](https://sagasudi.com/2024年-調剤報酬改定-地域体制加算１と２-10項目/)
- [【Q】ベルソムラ錠の粉砕の可否は？](https://sagasudi.com/【q】ベルソムラ錠の粉砕の可否は？/)
- [タミフルを脱カプセルした際の自家製剤加算は可能か?](https://sagasudi.com/738539-2/)
- [2023年6月に薬価収載予定の後発品 (新規成分)](https://sagasudi.com/202302news/)
- [地域体制加算を算定指定している薬局のお盆休みは？](https://sagasudi.com/3453938-2/)
- [ベナパスタ軟膏4%販売中止 経過措置期間は?](https://sagasudi.com/48359349-2/)
- [レキサルティ錠の経過措置期間は？](https://sagasudi.com/438953-2/)
- [ドレニゾンテープの経過措置期間は？](https://sagasudi.com/398438-2/)
- [自家製剤加算は一つの処方箋で重ねて加算できるか?](https://sagasudi.com/2837281-2/)
- [パキロビッド・ゾコーバ・ラゲブリオは薬局間譲渡可能か？](https://sagasudi.com/5652-2/)
- [新型コロナが５類になり 2023年5月8日から薬局で変わること ](https://sagasudi.com/392843-2/)
- [【Q】ルマケラス錠120mgの処方日数の投与制限は?](https://sagasudi.com/784526-2/)
- [【Q】リフヌア錠４５ｍｇの処方日数の投与制限は?](https://sagasudi.com/45356-2/)
- [「SAGASU-DI」は薬局薬剤師に向けたDI情報サイトとして有用
](https://sagasudi.com/paper38539/)
- [【Q】マンジャロ皮下注アテオスの処方日数の投与制限は?](https://sagasudi.com/【q】マンジャロ皮下注アテオスの処方日数の投与/)
- [管理薬剤師を変更するときに必要な書類 まとめ](https://sagasudi.com/管理薬剤師を変更するときに必要な書類-まとめ/)
- [グラアルファ配合点眼液は投与日数制限はあるか？](https://sagasudi.com/202212081-3/)
- [リバゼブ配合錠LD•HDの日数投与制限は？](https://sagasudi.com/202212081-2/)
- [2022年12月に薬価収載予定の後発品](https://sagasudi.com/news20220919/)
- [ゾコーバ錠の特徴は？簡潔に](https://sagasudi.com/20221128-2/)
- [エクセラーぜ配合錠 販売中止](https://sagasudi.com/news20221013/)
- [リフィル処方箋の注意点は？](https://sagasudi.com/hoki220929/)
- [【NEWS】2022年6月 発売予定の後発品 (ジェネリック)](https://sagas
…Machine-readable: GET /v1/resolve?q=sagasudi.com · GET /v1/domain/sagasudi.com · this page as Accept: application/json or text/markdown · MCP lookup_domain
Automatically discovered from public files. Inclusion does not imply endorsement or publisher participation.
Own or manage this website?
If you own or manage sagasudi.com, you can update its listing and review file health, discovery activity and score history.
Manage this listing — optional
What verification unlocks
See how your site is discovered—and control what agents see.
- See your website in the map
Review your indexed topics, nearby publishers sharing headings, measured listing exposure and map snapshots in a private report for your website.
- Control what agents see
Edit your listing description, tags, public contact details and additional llms.txt paths. Publish your terms for automated access, attribution and pricing.
- Make your profile eligible for search
A valid, listed, unblocked, verified profile can appear in our publisher sitemap and become eligible for search-engine visibility. Search engines decide what to index and rank.
- Appear in our llms-full.txt
Eligible verified publishers are listed by name, with their file links and summaries, in the service overview agents can read.
Free. No account registration, backlink or payment required. Public discovery remains available without verification.
Let your coding agent verify it
If your coding agent is authorized to manage this website, paste these instructions into it.
Claim my listing on Agent Web Map for sagasudi.com:
1. POST https://agentwebmap.com/v1/sites/sagasudi.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://sagasudi.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/sagasudi.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/sagasudi.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verifyCorrections or removal requests: contact the directory.